Outset Medical, Inc.
OM
$13.76
-$0.44-3.10%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 28.09% | -0.57% | 8.24% | 18.91% | 13.74% |
Total Depreciation and Amortization | -10.74% | -7.97% | 1.08% | -5.44% | 0.75% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -53.50% | 101.41% | -11.49% | -44.63% | 43.87% |
Change in Net Operating Assets | 157.75% | -703.36% | 603.38% | 96.52% | 22.99% |
Cash from Operations | 81.21% | -55.65% | 19.84% | 38.30% | 27.39% |
Capital Expenditure | -137.40% | -186.05% | 89.11% | -229.17% | 66.10% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 60.40% | -172.05% | 565.00% | -58.35% | 166.57% |
Cash from Investing | 60.09% | -172.19% | 581.28% | -59.23% | 165.97% |
Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
Total Debt Repaid | 100.00% | -- | -- | -- | -- |
Issuance of Common Stock | -100.00% | -- | -100.00% | 57.14% | -96.31% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.69% | 6,033.48% | -875.21% | 57.14% | -99.89% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 24.37% | -153.00% | 2,084.41% | -180.45% | 115.64% |